BrightSpring Q2 Revenue Up 29%, Guidance Raised

BrightSpring Health Services (NASDAQ:BTSG) reported Q2 2025 revenue of $3.15 billion, up 29.1% year-over-year and surpassing analyst expectations. Adjusted EPS rose to $0.22, exceeding consensus estimates by over 15%. The company raised its full-year revenue and EBITDA guidance to $12.4 billion and $597.5 million, respectively. Pharmacy Solutions contributed nearly 89% of quarterly revenue, and BrightSpring now serves over 460,000 patients daily across all 50 states, Puerto Rico, and Canada. Despite strong revenue and adjusted earnings growth, net income from continuing operations was flat year-over-year, and the operating margin held steady at 1.5%. The company attributes its robust performance to integrated pharmacy and provider services for complex patient populations.